Total Payments
$3,656
2024 Payments
$1,455
Companies
23
Transactions
140
Medicare Patients
2,970
Medicare Billing
$206,808
Payment Breakdown by Category
Food & Beverage$3,445 (94.2%)
Education$210.99 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,445 | 138 | 94.2% |
| Education | $210.99 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $719.44 | 19 | $0 (2024) |
| ABBVIE INC. | $647.34 | 33 | $0 (2024) |
| PFIZER INC. | $261.54 | 7 | $0 (2024) |
| Incyte Corporation | $230.23 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $229.03 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $222.19 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $210.33 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $159.06 | 7 | $0 (2024) |
| Amgen Inc. | $155.14 | 6 | $0 (2024) |
| Lilly USA, LLC | $144.20 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,455 | 64 | GENZYME CORPORATION ($364.81) |
| 2023 | $978.13 | 47 | AbbVie Inc. ($293.67) |
| 2022 | $769.58 | 22 | ABBVIE INC. ($169.64) |
| 2021 | $14.96 | 1 | Acera Surgical, Inc. ($14.96) |
| 2019 | $110.91 | 1 | GENZYME CORPORATION ($110.91) |
| 2017 | $327.24 | 5 | Celgene Corporation ($112.81) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.73 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.87 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.18 | General |
| Category: Immunology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.62 | General |
| Category: Immunology | ||||||
| 09/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.55 | General |
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.39 | General |
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.18 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 751 | 1,211 | $148,585 | $54,558 |
| 2022 | 12 | 804 | 1,200 | $268,468 | $55,107 |
| 2021 | 9 | 666 | 1,236 | $326,768 | $52,911 |
| 2020 | 12 | 749 | 1,283 | $307,106 | $44,231 |
Total Patients
2,970
Total Services
4,930
Medicare Billing
$206,808
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 218 | $32,700 | $14,527 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 104 | $20,800 | $9,389 | 45.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 84 | 97 | $16,975 | $7,939 | 46.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 82 | 95 | $21,375 | $5,761 | 27.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 103 | 125 | $15,625 | $4,260 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $9,600 | $3,143 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,325 | $2,888 | 45.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 21 | $4,300 | $2,000 | 46.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 73 | 382 | $13,370 | $1,925 | 14.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 41 | $4,100 | $1,573 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,625 | $573.17 | 35.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 15 | $1,500 | $559.39 | 37.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 29 | $290.00 | $23.11 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 150 | $59,900 | $12,623 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 141 | $35,070 | $8,579 | 24.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 94 | 112 | $49,013 | $8,380 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 77 | 77 | $16,200 | $6,662 | 41.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 97 | 105 | $38,453 | $6,660 | 17.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 118 | 134 | $33,905 | $4,425 | 13.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,475 | $2,534 | 39.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 48 | $8,748 | $1,929 | 22.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 75 | 346 | $12,110 | $1,716 | 14.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $4,228 | $1,097 | 25.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 11 | 11 | $4,044 | $464.43 | 11.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 45 | $322.00 | $39.19 | 12.2% |
About Dr. Stephanie Carstens, MD
Dr. Stephanie Carstens, MD is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1518252501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Carstens, MD has received a total of $3,656 in payments from pharmaceutical and medical device companies, with $1,455 received in 2024. These payments were reported across 140 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,445).
As a Medicare-enrolled provider, Carstens has provided services to 2,970 Medicare beneficiaries, totaling 4,930 services with total Medicare billing of $206,808. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 06/17/2011
- Last Updated 04/19/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518252501
Products in Payments
- DUPIXENT (Biological) $750.68
- RINVOQ (Biological) $407.51
- Otezla (Drug) $263.09
- SKYRIZI (Biological) $231.92
- OPZELURA (Drug) $230.23
- TREMFYA (Drug) $209.14
- DUPIXENT (Drug) $190.95
- Sotyktu (Drug) $186.53
- EUCRISA (Drug) $150.54
- ADBRY (Biological) $119.22
- TALTZ (Drug) $117.61
- COSENTYX (Drug) $113.73
- CIBINQO (Drug) $111.00
- ACZONE (Drug) $83.92
- SPEVIGO (Drug) $51.77
- Zoryve (Drug) $44.60
- VTAMA (Drug) $43.95
- Bimzelx (Biological) $35.73
- OLUMIANT (Drug) $26.59
- Klisyri (Drug) $23.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Dermatology $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Dermatology $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Dermatology $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dermatology $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Dermatology $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
Dermatology $14,036